Sign In
NewsRadar

Xceleron Ltd

Xceleron is using the nanotechnology of accelerator mass spectrometry (AMS) in drug development. Xceleron's technologies have been proven to speed drug development and reduce attrition rates.

• Show past press releases
• Edit this company

Contact Information
Address:
 
 

Phone:
Fax:
Web:
Contact:
 
 
York Biocentre
Innovation Way
Heslington, York YO10 5NY
United Kingdom
+44 (0)1904 561 561
+44 (0)1904 561 560
http://www.xceleron.co.uk
Michael Butler
+44 (0)1904 561 561

Company Facts
Founded:Dec 1997
Founders:Colin Garner
CEO:Michael Butler
CTO or technical lead:Graham Lappin
CFO or finance director:Ian Bedford
Head of Sales:Jeremy Hague
Head of Marketing:

Stage:Growth
Category:Biotechnology & Healthcare
Sector:Biotechnology
Employees:
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:

Non-executive Board Members

  • Philip Morgan
  • Ian Buckley Golder
  • Graham Gilbert
  • Ed Lascelles

    Key Customers

    Key Business Partners

    Key Competitors

    Capital Raised
    DateSizeInvestors
    To view this information you must be signed in and subscribed to the online dataservice, sign in here.

    To read more about the Online data service click here

    Public Offerings
    DateTypeExchange
    No public offerings


  • Data


    26,673
    Tech investments
    From our Online Data Service
    17,217
    VC-backed companies
    From our Radar


    Recent Deals


    DATEAMOUNTSECTOR
    Nov 25€24.0MInternet commerce
    Feb 14€19.0MBiopharmaceuticals
    Feb 14N/AInternet services
    Feb 14€4.6MBusiness applications
    Feb 13€13.0MBiopharmaceuticals
    Feb 13€25.0MMedical devices
    Feb 13€15.0MBusiness applications

    For information on Europe's most extensive database on technology funding click here!

    Events



    Press Releases


    May 28
    Identiq
    identiq raises $5m seed, launches privacy-first identity validation...

    Apr 29
    Nethone
    nethone raised over $1 million from innovation nest

    Jan 29
    Yumpingo
    yumpingo raises $10m to transform guest experiences in restaurants

    Oct 1
    The Link App
    the link app launches version 2.0

    Mar 29
    Addex Therapeutics
    addex sucessfully raises chf40 million in capital increase





    About usContact usLegal Information
    Copyright 1999-2019
    Emerging Technology Research Europe Inc. All rights reserved.